BioXcel Therapeutics (BTAI) Receivables - Other (2018 - 2019)
BioXcel Therapeutics (BTAI) recorded quarterly Receivables - Other of $82000.0 in Q4 2019, down 52.6% quarter-over-quarter from $173000.0 in Q3 2019, and down 28.7% on a YoY basis from $115000.0 in Q4 2018.
BioXcel Therapeutics (BTAI) Receivables - Other (2018 - 2019) Analysis & Trends
BioXcel Therapeutics' Receivables - Other history runs 2 years deep, the most recent figure standing at $82000.0 for Q4 2019.
- In Q4 2019, Receivables - Other fell 28.7% year-over-year to $82000.0; the TTM figure through Dec 2019 stood at $82000.0 (down 28.7% YoY), while the FY2019 annual figure was $82000.0, down 28.7% from the prior year.
- Receivables - Other was $82000.0 for Q4 2019 at BioXcel Therapeutics, down from $173000.0 in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $422000.0 in Q2 2019 to a low of $44000.0 in Q1 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | BioXcel Therapeutics | 25.46 Mn | 25.46 Mn | -77,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 82,000.00 |
| Dec 31, 2019 | 82,000.00 |
| Sep 30, 2019 | 173,000.00 |
| Sep 30, 2019 | 173,000.00 |
| Jun 30, 2019 | 422,000.00 |
| Jun 30, 2019 | 422,000.00 |
| Mar 31, 2019 | 291,000.00 |
| Mar 31, 2019 | 291,000.00 |
| Dec 31, 2018 | 115,000.00 |
| Dec 31, 2018 | 115,000.00 |
| Sep 30, 2018 | 49,000.00 |
| Sep 30, 2018 | 49,000.00 |
| Jun 30, 2018 | 70,000.00 |
| Jun 30, 2018 | 70,000.00 |
| Mar 31, 2018 | 44,000.00 |
| Mar 31, 2018 | 44,000.00 |